The e-Journal of Medical and Pharmaceutical Science (eJMPS) is committed to maintaining the highest standards of research integrity and ethical publishing. Research misconduct includes, but is not limited to, plagiarism, self-plagiarism, data fabrication, data falsification, image manipulation, duplicate publication, inappropriate authorship, citation manipulation, undisclosed conflicts of interest, and unethical research practices.

All allegations of research misconduct will be investigated fairly, confidentially, and in accordance with established ethical guidelines. Authors may be required to provide original data, ethical approval documents, consent forms, or other supporting materials to verify the integrity of their work.

If misconduct is suspected before publication, the manuscript may be rejected or returned for clarification. If misconduct is confirmed after publication, the journal may issue corrections, expressions of concern, or retract the article as appropriate. The journal reserves the right to notify authors’ institutions, funding agencies, or relevant authorities when serious ethical violations are identified.

eJMPS follows the recommendations of the Committee on Publication Ethics (COPE) and is committed to safeguarding the integrity, reliability, and credibility of the scholarly record.